BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 22721655)

  • 1. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
    Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
    JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
    JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
    Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
    JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.
    White AJ; Kedia G; Mirocha JM; Lee MS; Forrester JS; Morales WC; Dohad S; Kar S; Czer LS; Fontana GP; Trento A; Shah PK; Makkar RR
    JACC Cardiovasc Interv; 2008 Jun; 1(3):236-45. PubMed ID: 19463306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?
    Yap CH; Yan BP; Akowuah E; Dinh DT; Smith JA; Shardey GC; Tatoulis J; Skillington PD; Newcomb A; Mohajeri M; Pick A; Seevanayagam S; Reid CM
    JACC Cardiovasc Interv; 2009 Aug; 2(8):758-64. PubMed ID: 19695544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.
    Capodanno D; Capranzano P; Di Salvo ME; Caggegi A; Tomasello D; Cincotta G; Miano M; Patané M; Tamburino C; Tolaro S; Patané L; Calafiore AM; Tamburino C
    JACC Cardiovasc Interv; 2009 Aug; 2(8):731-8. PubMed ID: 19695541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
    Garg S; Serruys PW; Silber S; Wykrzykowska J; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; DiMario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli A; Van Remortel E; Ronden J; Windecker S
    JACC Cardiovasc Interv; 2011 Apr; 4(4):432-41. PubMed ID: 21511223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of percutaneous coronary intervention and coronary artery bypass grafts for ostial right coronary lesions in propensity-matched individuals.
    Gan HL; Zhang JQ; Huang F; Gu CX; Kong QY; Cao XR; Bo P; Lu CS
    Cardiovasc Ther; 2011 Dec; 29(6):395-403. PubMed ID: 20718758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.
    Zheng Z; Xu B; Zhang H; Guan C; Xian Y; Zhao Y; Fan H; Yang Y; Wang W; Gao R; Hu S
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1102-11. PubMed ID: 27282597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating the EXCEL hypothesis: a propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32.
    Capodanno D; Caggegi A; Capranzano P; Cincotta G; Miano M; Barrano G; Monaco S; Calvo F; Tamburino C
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):936-43. PubMed ID: 21547994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.